Business Context and Reporting Period
Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2000 (First Quarter of Fiscal 2001)
Business Overview: The Company manufactures and distributes dietary supplements, vitamins, and herbal products. Operations include facilities in San Marcos, California, and Lugano, Switzerland. The Company is currently executing a cost containment program following the loss of a major customer, NuSkin Enterprises, Inc.
Key Financial Metrics
| Metric | Q1 2001 (Sep 30, 2000) | Q1 2000 (Sep 30, 1999) |
|---|---|---|
| Net Sales | $10,223,000 | $15,264,000 |
| Gross Profit | $2,011,000 | $3,189,000 |
| Gross Margin | 19.7% | 20.9% |
| Net Earnings | $205,000 | $87,000 |
| Diluted EPS | $0.04 | $0.02 |
| Operating Cash Flow | $433,000 | $1,401,000 |
| Total Debt (Outstanding) | $8,100,000 | $8,400,000 (approx.) |
| Cash and Equivalents | $803,000 | $955,000 |
| Working Capital | $7,802,000 | $7,595,000 (approx.) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 33% ($5.0 million) year-over-year. This was primarily driven by the complete loss of sales to NuSkin Enterprises, Inc. (approx. $3.0 million in the prior year) and reduced sales to two other customers totaling $1.8 million.
- Profitability Improvement: Despite the revenue drop, Net Earnings increased 135% to $205,000. This was achieved through a rigorous cost containment program, including a 27% workforce reduction and the termination of a long-term lease obligation (Carlsbad facility) which resulted in a $3.0 million settlement fee in the prior year but eliminated ongoing costs.
- Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased by $791,000 to $1.7 million, representing 17% of sales in both periods.
- Tax Benefit: The effective tax rate shifted from a 75% expense in the prior year to a 52% benefit in the current quarter, largely due to a tax holiday for the profitable Swiss subsidiary and a net loss in U.S. operations.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook
Management is focused on restoring net profits by maintaining operating cost structures aligned with current sales levels. The Company is diversifying revenue through the "Dr. Cherry" label (sales exceeded $1.0 million in Q1), the Custom Nutrition joint venture, and international expansion via the Swiss facility. The Company expects operating results to fluctuate.
Subsequent Events
- New Credit Facility: On November 13, 2000, the Company secured a commitment for a new $9.35 million credit facility to replace expiring lines of credit.
- Loan Extension: The Company extended the due date of a $830,000 convertible loan to its joint venture partner, FitnessAge, with a repayment schedule extending to September 2001.
Risks and Contingencies
- Customer Concentration: Two major customers accounted for 63% of net sales in Q1 2001. The loss of either would have a material adverse impact.
- Legal Proceedings: The Company is defending a lawsuit filed by a former executive (William P. Spencer) alleging damages in excess of $6.0 million. Management believes the claims are without merit but notes a judgment could materially impact financial condition.
- Debt Covenants: The Company was previously non-compliant with certain debt covenants but amended the agreement in July 2000 to achieve compliance. Future compliance depends on operating performance.
- Joint Venture Risk: The Company has a significant exposure ($980,000) to FitnessAge, a development-stage company, via equity and a convertible loan.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the top two customers representing 63% of revenue.
- Debt Renewal: Confirm the final terms and covenants of the new $9.35 million credit facility secured in November 2000.
- Legal Exposure: Monitor the status of the $6.0 million lawsuit filed by the former President/CFO.
- Joint Venture Solvency: Assess the ability of FitnessAge to repay the $830,000 loan or convert it to equity as scheduled.
- Swiss Operations: Evaluate the profitability and tax status of the Swiss subsidiary, which currently benefits from a tax holiday.